Regnery, S., Buchele, C., Weykamp, F., Pohl, M., Hoegen-Saßmannshausen, P., Eichkorn, T., . . . Hörner-Rieber, J. (2022). Adaptive MR-guided stereotactic radiotherapy is beneficial for ablative treatment of lung tumors in high-risk locations. Frontiers in oncology, 11, . https://doi.org/10.3389/fonc.2021.757031
Chicago Style (17th ed.) CitationRegnery, Sebastian, et al. "Adaptive MR-guided Stereotactic Radiotherapy Is Beneficial for Ablative Treatment of Lung Tumors in High-risk Locations." Frontiers in Oncology 11 (2022). https://doi.org/10.3389/fonc.2021.757031.
MLA (9th ed.) CitationRegnery, Sebastian, et al. "Adaptive MR-guided Stereotactic Radiotherapy Is Beneficial for Ablative Treatment of Lung Tumors in High-risk Locations." Frontiers in Oncology, vol. 11, 2022, https://doi.org/10.3389/fonc.2021.757031.